Genomic Classifier in Prostate Cancer: Active Surveillance Videos

Integrating Genomic Prognostic and Hallmark Signatures to Predict Outcomes in Active Surveillance - Kevin Shee

Analysis of Genomic Drivers of Discordant Risk Classifications in Prostate Cancer - Michael Zelefsky

Combining Genomic Classifier and Digital Pathology Artificial Intelligence in Prostate Cancer Risk Stratification - Daniel Spratt

Integrating Genomic Testing with MRI Enhances Stratification of Surveillance Patients - Eric Kim & Mark Sultan

2024 NCCN Guidelines: Simplifying the Management of Very Low-Risk Prostate Cancer - Rashid Sayyid & Zachary Klaassen

Precision Risk Assessment in Prostate Cancer: Growing Utility in NCCN Guidelines - Rashid Sayyid & Zachary Klaassen

Risk Assessment in Localized Prostate Cancer - Insights from Real-World Data and SEER Registry - Jim Hu

Active Surveillance: Optimizing the Quality of Life in Men with Localized Prostate Cancer - Preston Sprenkle & Randy Vince

Integrating the Use of Prostate Genomic Classifiers into Clinical Practice - A Clinical Pathway Approach - Katie Murray and Anne Lizardi-Calvaresi

The Molecular Biology of Prostate Cancer - Christopher Barbieri

Decipher® Biopsy and Decipher® for Prostatectomy in Clinical Practice- Ashley Ross

The Impact of Decipher® Biopsy Testing on Clinical Outcomes in Localized Prostate Cancer – Randy A. Vince Jr.

A Systematic Review of the Decipher® Genomic Classifier in Prostate Cancer - Ashley Ross & Daniel Spratt